The new report by Zion Market Research on the “Biologics Outsourcing Market by Product (Antibody, Recombinant Protein, Vaccines, and Others), by Type (Kits & Reagents and Instruments), by Sources (Microbial, Mammalian and Others) and for Applications (Vaccine & Therapeutics Development, Blood & Blood Related Products Testing, Cellular and Gene Therapy, Tissue and Tissue Related Products Testing, and Stem Cell Research): Global Industry Analysis, Size, Share, Growth, ... Read more
Biologics can be defined as drugs derived from living organisms, or those which contain components of living organisms. These include a range of products, including those derived from human, animals, or microorganisms by employing biotechnology.
Biologic drugs are available for the treatment of a range of diseases, including various forms of cancer, autoimmune diseases, chronic diseases, cardiovascular
The global Biologics Outsourcing market is estimated to be valued at US$ 19.67 billion in 2023 and is expected to exhibit a CAGR of 12.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
The Biologics Outsourcing market refers to the outsourcing of biological product manufacturing processes and services to external companies. This includes contract research organizations (CROs) and contract ... Read more
The global Biologics Outsourcing market is estimated to be valued at US$ 19.67 billion in 2023 and is expected to exhibit a CAGR of 12.9% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
A) Market Overview:
The Biologics Outsourcing market refers to the outsourcing of biological product manufacturing processes and services to external companies. This includes contract research organizations (CROs) and contract ... Read more
Biologics such as monoclonal antibodies, recombinant proteins, and vaccines have revolutionized the treatment of various diseases. Biologics are complex molecules manufactured through biological processes and they have large, complex structures that are far more difficult to characterize and reproduce than traditional small molecule drugs. Producing biologics requires highly specialized expertise and production facilities. Given the complex manufacturing processes and high capital ... Read more
